Vioxx (Rofecoxib) Withdrawl from the Market
FAQs
The decision was based on data from a three-year study. In this study, there was an increased risk for cardiovascular events, such as heart attack and stroke in patients taking VIOXX compared to those taking placebo (sugar pills). The increased risk to patients on Vioxx was small (1.48 cardiovascular events per 100 patient years compared with 0.75 events per 100 patients years on placebo) and not seen until after 18 months of treatment.
You should contact your health care provider to discuss alternative treatments that will best meet your individual needs.
No. Merck, the manufacturer of VIOXX has withdrawn all dosage strengths and formulations from the market.
Merck will reimburse all patients for their unused VIOXX including all dosage strengths and formulations. Information about returning your medicine can be found at vioxx.com or by calling 1-888-368-4699.
Additional information can be found at merck.com
and vioxx.com or by calling 1-888-368-4699
